References
Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350:2167–2179
Vidal F, Fontova R, Richart C (2003) Severe neutropenia and thrombocytopenia associated with infliximab. An Int Med 139:238–239
Favalli EG, Varenna M, Sinigaglia L (2005) Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clin Exp Rheumatol 23:247–250
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593
Lamy T, Loughran TP (2003) Clinical features of large granular lymphocyte leukemia. Sem Hem 40:185–195
Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP (2000) Chronic neutropenia mediated by fas ligand. Blood 95:3219–3222
Coacley G, Iqbal M, Brooks D, Panayi GS, Lanchbury JS (2000) CD8 + CD57 + T cells suppress neutrophil development in vitro: implications for the neutropenia of Felty’s and large granular lymphocyte syndromes. Arthritis Rheum 43:834–843
Keystone EC (2001) Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 27:427–443
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Theodoridou, A., Kartsios, C., Yiannaki, E. et al. Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy. Rheumatol Int 27, 201–202 (2006). https://doi.org/10.1007/s00296-006-0187-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-006-0187-3